{
  "url": "https://struct.news/briefs/bridgebio-doubled-six-month-revenue-but-receivables-grew-nearly-twice-as-fast",
  "title": "BridgeBio doubled six-month revenue, but receivables grew nearly twice as fast",
  "summary": "Receivables added $177.6 million in six months, more than the $133.1 million increase in revenue.",
  "published_at": "2026-08-10T20:49:53.211758+00:00",
  "publisher": "Struct",
  "usage": "Figures are as reported by the company. Quote with attribution to the source filing.",
  "company": {
    "name": "BridgeBio Pharma, Inc.",
    "ticker": "BBIO",
    "cik": "1743881",
    "sector": "Healthcare",
    "industry": "Biotechnology"
  },
  "source_filing": {
    "form": "10-Q",
    "filed": "2026-08-10",
    "accession": "0001743881-26-000027",
    "url": "https://www.sec.gov/Archives/edgar/data/1743881/000174388126000027/bbio-20260630.htm"
  },
  "comparison_filing": {
    "form": "10-Q",
    "filed": "2025-08-05",
    "url": "https://www.sec.gov/Archives/edgar/data/1743881/000095017025103192/bbio-20250630.htm"
  },
  "reported_figures": [
    {
      "group": "The filing in three numbers",
      "label": "Revenue",
      "value": 502076000,
      "display": "$502.1M",
      "unit": "usd",
      "period": "2025-12-31",
      "detail": null,
      "source": {
        "kind": "sec_filing",
        "label": "Filed company results",
        "form": "10-Q",
        "accession": "0001743881-26-000027",
        "filing_date": "2026-08-10"
      }
    },
    {
      "group": "The filing in three numbers",
      "label": "Revenue YoY",
      "value": 126.2602410072915,
      "display": "+126.3%",
      "unit": "percent",
      "period": "2025-12-31",
      "detail": null,
      "source": {
        "kind": "jodie_calculation",
        "label": "Calculated from filed company results",
        "form": "10-Q",
        "accession": "0001743881-26-000027",
        "filing_date": "2026-08-10"
      }
    },
    {
      "group": "The filing in three numbers",
      "label": "Operating margin",
      "value": -104.24935667110158,
      "display": "-104.2%",
      "unit": "percent",
      "period": "2025-12-31",
      "detail": null,
      "source": {
        "kind": "jodie_calculation",
        "label": "Calculated from filed company results",
        "form": "10-Q",
        "accession": "0001743881-26-000027",
        "filing_date": "2026-08-10"
      }
    }
  ],
  "watch_next": [
    {
      "type": "working_capital",
      "statement": "Receivables tied to net product revenues produced a major operating cash outflow as the commercial revenue base expanded.",
      "importance": "medium",
      "evidence": "The net cash outflow of $96.7 million related to changes in operating assets and liabilities was attributed mainly to an increase of $72.1 million in accounts receivable, net primarily related to receivables for net product revenues",
      "source_date": "2026-08-10"
    }
  ],
  "related_tickers": [
    "BBIO"
  ],
  "disclaimer": "Descriptive reporting of filed results. Not investment advice, and contains no forecast or recommendation."
}